Comparison of the in vitro pharmacological profiles of long-acting muscarinic antagonists in human bronchus

The observed differences in the LAMAs' in vitro pharmacological profiles in the human bronchus provide a compelling pharmacological rationale for the differences in the drugs' respective recommended daily doses and frequencies of administration.